CN111087442A - 一种多肽提取方法 - Google Patents
一种多肽提取方法 Download PDFInfo
- Publication number
- CN111087442A CN111087442A CN201911292507.8A CN201911292507A CN111087442A CN 111087442 A CN111087442 A CN 111087442A CN 201911292507 A CN201911292507 A CN 201911292507A CN 111087442 A CN111087442 A CN 111087442A
- Authority
- CN
- China
- Prior art keywords
- solution
- acetonitrile
- solid phase
- supernatant
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 21
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 21
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 21
- 238000000605 extraction Methods 0.000 title claims abstract description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 72
- 239000000243 solution Substances 0.000 claims abstract description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 22
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims abstract description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 15
- 210000002966 serum Anatomy 0.000 claims abstract description 14
- 239000006228 supernatant Substances 0.000 claims abstract description 14
- 239000003480 eluent Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 8
- 239000011259 mixed solution Substances 0.000 claims abstract description 7
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- 238000010790 dilution Methods 0.000 claims abstract description 3
- 239000012895 dilution Substances 0.000 claims abstract description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 238000011084 recovery Methods 0.000 abstract description 5
- 239000007790 solid phase Substances 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 description 6
- 210000004881 tumor cell Anatomy 0.000 description 6
- 238000002659 cell therapy Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000009169 immunotherapy Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000004807 desolvation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911292507.8A CN111087442B (zh) | 2019-12-12 | 2019-12-12 | 一种多肽提取方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911292507.8A CN111087442B (zh) | 2019-12-12 | 2019-12-12 | 一种多肽提取方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111087442A true CN111087442A (zh) | 2020-05-01 |
CN111087442B CN111087442B (zh) | 2024-03-12 |
Family
ID=70394994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911292507.8A Active CN111087442B (zh) | 2019-12-12 | 2019-12-12 | 一种多肽提取方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111087442B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115201360A (zh) * | 2022-07-04 | 2022-10-18 | 南京市公安局刑事侦查局 | 血、尿中氟乙酸的离子色谱串联三重四极杆质谱检测方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1337403A (zh) * | 2000-08-04 | 2002-02-27 | 中国药品生物制品检定所 | 从活性血多肽中分离的活性单肽、其制备工艺、活性及序列 |
CN101464430A (zh) * | 2007-12-21 | 2009-06-24 | 中国科学院大连化学物理研究所 | 一种内源性多肽在线富集和自动化分析的方法及专用装置 |
CN103134860A (zh) * | 2011-11-23 | 2013-06-05 | 上海市公共卫生临床中心 | 一种目标多肽和蛋白质定量测定方法 |
CN106146607A (zh) * | 2015-04-09 | 2016-11-23 | 深圳华大基因研究院 | 一种多肽提取纯化方法和试剂盒 |
CN106268707A (zh) * | 2016-08-11 | 2017-01-04 | 北京蛋白质组研究中心 | 一种基于新型磁性多孔材料的磷酸肽富集新方法 |
-
2019
- 2019-12-12 CN CN201911292507.8A patent/CN111087442B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1337403A (zh) * | 2000-08-04 | 2002-02-27 | 中国药品生物制品检定所 | 从活性血多肽中分离的活性单肽、其制备工艺、活性及序列 |
CN101464430A (zh) * | 2007-12-21 | 2009-06-24 | 中国科学院大连化学物理研究所 | 一种内源性多肽在线富集和自动化分析的方法及专用装置 |
CN103134860A (zh) * | 2011-11-23 | 2013-06-05 | 上海市公共卫生临床中心 | 一种目标多肽和蛋白质定量测定方法 |
CN106146607A (zh) * | 2015-04-09 | 2016-11-23 | 深圳华大基因研究院 | 一种多肽提取纯化方法和试剂盒 |
CN106268707A (zh) * | 2016-08-11 | 2017-01-04 | 北京蛋白质组研究中心 | 一种基于新型磁性多孔材料的磷酸肽富集新方法 |
Non-Patent Citations (2)
Title |
---|
徐友宣, 王超, 彭师奇, 赵明: "含P6A寡肽血液的HPLC分离分析", 中国新药杂志, no. 07, pages 148 - 102 * |
李力等: "中药成分体内代谢与分析研究", 广西科学技术出版社, pages: 148 - 102 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115201360A (zh) * | 2022-07-04 | 2022-10-18 | 南京市公安局刑事侦查局 | 血、尿中氟乙酸的离子色谱串联三重四极杆质谱检测方法 |
CN115201360B (zh) * | 2022-07-04 | 2024-03-26 | 南京市公安局刑事侦查局 | 血、尿中氟乙酸的离子色谱串联三重四极杆质谱检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111087442B (zh) | 2024-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10548853B2 (en) | Oncolytic virus formulation and preparation method thereof | |
US11986553B2 (en) | Multi-component injection | |
CN109310712A (zh) | 用于医学的人血小板裂解物来源细胞外囊泡 | |
DK160288B (da) | Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanser | |
Itoh et al. | Blazein of a new steroid isolated from Agaricus blazei Murrill (himematsutake) induces cell death and morphological change indicative of apoptotic chromatin condensation in human lung cancer LU99 and stomach cancer KATO III cells | |
CN111087442A (zh) | 一种多肽提取方法 | |
CN111116702A (zh) | 一种多肽提取组合物及试剂盒 | |
Sachdev et al. | Isolation and characterization of glycoproteins from canine tracheal mucus | |
JP5172864B2 (ja) | 抗腫瘍ワクチン、抗腫瘍ワクチンの調製方法及び抗腫瘍免疫療法の実行方法 | |
RU2593003C2 (ru) | Препарат экзосом - онкосом и способ иммунотерапии солидных опухолей с его использованием | |
CN111748024A (zh) | 美洲大蠊多肽的制备方法 | |
CN103739698B (zh) | 梅花鹿鹿茸胸腺素β10重组蛋白及其制备方法和用途 | |
CN110172449A (zh) | 一种白血病细胞外泌体及其制备方法和应用 | |
CN1994463A (zh) | 一种免疫制剂的制备和用途 | |
US4228068A (en) | Peptide complexes of DNA-containing organisms | |
CN112716947A (zh) | 从骆驼蓬中提取分离的γ-去氢骆驼蓬碱在制备抑制胃癌药物中的应用 | |
CN104974236A (zh) | 一种蝎毒多肽b4及其分离纯化方法与应用 | |
Wolf et al. | Preparation and purification of plasma membranes from murine lymphoma cells carrying tumour-specific antigenicity | |
JP4480204B2 (ja) | カワリハラタケの抗腫瘍性画分 | |
TWI618540B (zh) | Composition for preventing renal toxicity caused by drug toxicity, preparation method thereof and Its use | |
CN110664821A (zh) | 人参二醇在制备抑制pd-l1、肿瘤细胞增殖蛋白的表达的药物中的应用 | |
CN110604814A (zh) | 纯化的多亚型热休克蛋白/肽复合物多联肿瘤疫苗及其制备方法 | |
RU2038087C1 (ru) | Способ получения вещества из кожи свиньи, влияющего на пролиферацию и дифференцировку кератиноцитов человека | |
CN116549482B (zh) | 人参多糖在制备免疫调节产品中的应用 | |
CN115894629B (zh) | 定向诱导间充质干细胞制备的活性肽及其制备方法与在治疗肺癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Country or region after: China Address after: Room 501, 5th Floor, Building 3, Runjiang Headquarters International, No. 455 Yuhua East Road, High tech Zone, Shijiazhuang City, Hebei Province, 050000 Applicant after: Shijiazhuang Boke Medical Laboratory Co.,Ltd. Address before: Building 3, Runjiang Headquarters International, No. 319 Changjiang Avenue, High tech Zone, Shijiazhuang City, Hebei Province, 050000 Applicant before: Shijiazhuang hi tech Zone Boke medical laboratory Co.,Ltd. Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |